Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-05-04
1995-08-22
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514290, 546 4, 546 10, 546110, 546153, 546155, 546156, 546157, A61K 3147, C07D215233
Patent
active
054440718
ABSTRACT:
The invention concerns pharmaceutically useful novel compounds of the formula I, in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, Ra, A, X and Z have the various meanings defined herein, and their non-toxic salts, and pharmaceutical compositions containing them. The novel compounds are of value in treating conditions such as hypertension and congestive heart failure. The invention further concerns processes for the manufacture of the novel compounds and the use of the compounds in medical treatment. ##STR1##
REFERENCES:
patent: 4576953 (1986-03-01), Le Count
patent: 4607040 (1986-08-01), Pearce et al.
patent: 4820843 (1989-04-01), Aldrich et al.
patent: 4880804 (1989-11-01), Carini et al.
patent: 4920131 (1990-04-01), Huang et al.
patent: 5028615 (1991-07-01), Huang et al.
patent: 5219863 (1993-07-01), Roberts et al.
patent: 5227387 (1993-07-01), Dreikorn et al.
patent: 5240940 (1993-08-01), Arnold et al.
patent: 5246944 (1993-09-01), Greenlee et al.
patent: 5296484 (1994-03-01), Coghlan et al.
Youssefyeh, R. D., et al. (principal author Huang) J. Med. Chem. (1990), 33, 1186-1194.
Chem. Abstr. (1990), 112, 17, Abstract 131,890u.
Huang, F-C J. Med. Chem. (1990), 33, 1194-1200.
J. Chem. Soc., Perkin Trans. 1, (14), 1803-8, (1972) by Proctor et al.
M. I. Husain, et al., J. Chem. Soc. Pak. (1986) 8(3), 335-9.
Pearce Robert J.
Roberts David A.
Russell Simon T.
Gupta Yogendra N.
Imperial Chemical Industries plc
LandOfFree
Quinoline derivatives and use thereof as angiotensin II antagoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline derivatives and use thereof as angiotensin II antagoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline derivatives and use thereof as angiotensin II antagoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2142043